This article is a note for:
Volume 53, Number 1, January-March 2018
|Page(s)||67 - 68|
|Published online||07 March 2018|
Letter to the editor
Comments on “Radiation induced breast cancer risk in BRCA mutation carriers from low-dose radiological exposures: a systematic review”
Radioprotection 52(4), 231–240, DOI: 10.1051/radiopro/2017034
343 Adair Drive,
2 Department of Radiation Oncology, Loyola Stritch School of Medicine and Hines VA Hospital, Chicago, IL, USA
3 Department of Diagnostic Imaging, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA 19111, USA
4 Ionizing and Non-ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran
* Corresponding author: S.M.Javad.Mortazavi@fccc.edu; firstname.lastname@example.org
Accepted: 6 February 2018
Key words: radiation / breast cancer / BRCA / low dose radiation / radiological examinations
This letter is regarding the article by Colin et al., entitled “Radiation induced breast cancer risk in BRCA mutation carriers from low-dose radiological exposures: a systematic review”, published in Radioprotection (Colin et al., 2017). The authors claim that based on the review they performed on 11 studies which included many types of radiological breast exposures, an association between the risk of breast cancer (BC) and low cumulative X-ray doses below the age of 30 was found. The authors concluded that 1) the risk of radiation induced breast cancers in BRCA mutation carriers depends on women’s age at exposure, and 2) mammography or any repeated X-ray exposures of breast should be limited and used very cautiously in these mutation carriers.
The reason for the increased concerns regarding X-ray imaging in BRCA mutation carriers is that such patients have deficiencies in DNA double-strand break (DSB) repair, and so may face increased risk of cancer based on the somatic mutation model of cancer. However, DNA damage does occur due to endogenous causes and such damage is much higher than the DNA damage caused by low levels of radiation such as from diagnostic X-ray exposures. Also, the increased damage from low-dose radiation would boost defenses such as antioxidants and DNA repair enzymes which would result in reduced DNA damage from endogenous causes, with the ultimate result being reduced net DNA damage. In addition, low-dose radiation also boosts the immune system and so would eliminate the cancer cells more effectively, reducing the cancer risk. Thus, there is no radiobiological reason for the cancer concerns regarding diagnostic X-ray procedures.
There is also no consistent evidence to support the cancer concerns regarding the X-rays, as indicated by the authors’ review of the literature. A review of the epidemiological studies used by Colin et al. showed that 1) The findings are inconsistent between the studies and so do not allow any firm conclusions. Moreover, in some cases such as the study conducted by Goldfrank et al. (2006), the association with breast cancer was positive only for BRCA1 with an OR of 1.08. 2) The heterogeneity of the types of diagnostic procedures in these studies makes the comparison of the findings of different studies very complicated. For example, while in 7 studies the procedure was either mammography or chest radiography, Pijpe et al.’s study included computed tomography (Pijpe et al., 2012). It is worth noting that considering the Table 3 in the paper authored by Colin et al., if they limit the exposures to only radiography (to reduce the heterogeneity and to make the comparison of the studies more accurate), currently positive marked association with breast cancer would become negative. 3) Interestingly, in one of the papers reviewed by Colin et al. (John et al., 2013), the OR was not increased for 6 or more chest X-rays, while it was elevated for BRCA2 mutation carriers with 3–5 diagnostic chest X-rays. 4). As indicated in some of these epidemiological reports (e.g., Andrieu et al. (2006)), recall bias could have affected the findings.
The number of natural mutations is significantly larger than those created by low-dose ionizing radiation. If low-dose radiation is a hazard, one would expect that the natural mutations would propagate cancer at a rate larger than observed. Since this does not occur, the DNA repair mechanisms and human immune system must function efficiently to remove both naturally occurring abnormalities and those caused by low-doses of ionizing radiation. Although this is a very qualitative argument, the rate of natural mutations suggests that the DNA repair mechanisms should mitigate the detrimental effects of low-dose ionizing radiation observed by Colin et al. In summary, there is no radiobiological reason for the cancer concerns due to X-ray scans and there is no consistent epidemiological evidence to support the concerns.
- Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Van’t Veer L, Van Leeuwen FE, Goldgar DE. 2006. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group, J. Clin. Oncol. 24: 3361–3366. [CrossRef] [PubMed] [Google Scholar]
- Colin C, Foray N, Di Leo G, Sardanelli F. 2017. Radiation induced breast cancer risk in BRCA mutation carriers from low-dose radiological exposures: a systematic review. Radioprotection 52(4): 231–240. [CrossRef] [EDP Sciences] [Google Scholar]
- Goldfrank D, Chuai S, Bernstein JL, Ramon YCT, Lee JB, Alonso MC, Diez O, Baiget M, Kauff ND, Offit K, Robson M. 2006. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol. Biomark. Prev. 15: 2311–2313. [CrossRef] [PubMed] [Google Scholar]
- John EM, Mcguire V, Thomas D, Haile R, Ozcelik H, Milne RL, Felberg A, West DW, Miron A, Knight JA, Terry MB, Daly M, Buys SS, Andrulis IL, Hopper JL, Southey MC, Giles GG, Apicella C, Thorne H, Whittemore AS. 2013. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol. Biomark. Prev. 22: 1547–1556. [CrossRef] [PubMed] [Google Scholar]
- Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Noguès C, Gauthier-Villars M, Lasset C, Fricker J-P, Peock S, Frost D, Evans DG, Eeles RA, Paterson J, Manders P, Van Asperen CJ, Ausems MGEM, Meijers-Heijboer H, Thierry-Chef I, Hauptmann M, Goldgar D, Rookus MA, Van Leeuwen FE. 2012. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ: Br Med J. 345: e5660. [CrossRef] [PubMed] [Google Scholar]
Cite this article as: Bevelacqua JJ, Welsh J, Mortazavi SMJ, Doss M. 2018. Comments on “Radiation induced breast cancer risk in BRCA mutation carriers from low-dose radiological exposures: a systematic review”. Radioprotection 53(1): 67–68
© EDP Sciences 2018
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.